Use of rituximab appears to be safe, and may enable some patients with chronic immune thrombocytopenic purpura to avoid splenectomy, French researchers report in the August 15th issue of Blood.
Reuters Health Information
Source: http://www.medscape.com/pharmacists?src=rss
Medscape Pharmacists Headlines